FR-027

N/A

Report date: 2025/06/11 10:27:41
NME

Base Information

Drug NameFR-027
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionExportin-1 protein inhibitors
TargetsExportin-1 protein
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKu Leuven
China Registration ClassN/A

Develop Information

Active CompaniesKu Leuven
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A